News and Events

  • Tarcine BioMed Be Invited to Introduce Early Warning System for Cancer Screening and NPC Biomarker Rta at 11th Congress of the International Society of Nutrigenetics and Nutrigenomics)

    11th Congress of the International Society of Nutrigenetics and Nutrigenomics was held at Medical Centre of UCLA during 16-19 September 2017. 200 scientists, entrepreneurs and doctors from USA, Canada, UK, Italy, New Zealand, German, Spain and China participated.  Prof Ray Jiao, CEO of Tarcine BioMed, was invited to present a lecture on “Early Warning System for Cancer Screening and Targeted N ...

    Detail
  • Tarcine BioMed Awarded Patent on Rta CLIA

    Tarcine BioMed has awarded a patent certificate on Rta/IgG of EB virus CLIA reagent and its application from China Intellectual Property Bureau. This new invented product can detect the Rta/IgG of EB virus in the specimen fast, accurately, sensitively and specifically. Moreover multi-specimens can be tested simultaneously, so the processing time can be reduced for enhancing the effectiveness. Rta/ ...

    Detail
  • Forum on Rta for NPC Screening in Hefei

    From August 2016, Tarcine BioMed has been collaborating with Chine Health Promotion Foundation to start a campaign to promote NPC Screening at health management organizations. On 21st October 2016, China Health Promotion Foundation organized a forum on “Research on Application of NPC Screening on Health Check and Risk Management at Multi-center”. Over 20 specialists on health check from variou ...

    Detail
  • Tarcine Research Product Be Patented in Hong Kong

    Tarcine BioMed has got the patent from Intellectual Property Department of HKSAR on the manufacturing process of Lp-PLA2 Chemiluminescence Immuno Assay (CLIA) kit which is developed by Tarcine BioMed. The noise of this CLIA kit is reduced to the greatest limit, so the differentiation of the detection light and the baseline is strengthened resulting in enhanced specificity. The application of thi ...

    Detail
  • China Health Promotion Foundation Medical Group Includes Rta (NPCheck) in Early Screening of Nasopharyngeal Carcinoma in Physical Examination Program

    The symposium titled“multi-center studies of applications of early screening Program in Nasopharyngeal Carcinoma ” took place in city of Changsha on 27th August, 2016. China Health Promotion Foundation and Central South University Xiangya Hospital co-hosted this symposium. More than 60 KOLs from dozens of clinical departments of medical centers and hospitals attended this event.  Recently, t ...

    Detail
  • The Global Healthcare Program has been launched in USA

    Tarcine USA officially launched the Global Healthcare Program in Los Angeles, California. With years of experiences in Southern California health system connections to Southern California local networks, Tarcine offers executive health with an option of personalized tour. To create a personalized global health package for our Chinese clients, Tarcine USA has collaborated with the top three prestig ...

    Detail
  • Tarcine Biomed attended 2015 AACC Expo

    Tarcine BioMed attended the 67th American Association for Clinical Chemistry (AACC) Annual meeting & Clinical Lab Expo, the world’s largest show for Clinical Chemistry in Atlanta, Georgia during July 28th – 30th, 2015. More than 700 exhibitors filled the show floor of Atlanta’s convention center, with displays of the latest diagnostic technologies, including but not limited to mobile hea ...

    Detail
  • Tarcine Biotechnic Diagnostics becomes Distributor of Beijing Richen Force in Hong Kong

    From May 2015, Tarcine Biotechnic Diagnostics has been the distributor of Beijing Richen-force Science & Technology Co. for their C13 Urea Breath Test kits in Hong Kong. Beijing Richen-force Science & Technology Co. is the largest manufacturer of C13 Breath Test in the world. ISO9001, ISO13485 and CE have been awarded and their products are selling in over 50 countries. ...

    Detail
  • Tarcine Signed MOU with POC Medical Systems

    Westlake Village, CA- Apr.22, 2015 – Tarcine BioMed USA, Inc. today announced that Tarcine BioMed Inc. (Hong Kong) has officially signed a Memorandum of Understanding (MOU) with POC Medical Systems, Inc. (Livermore, CA).  Tarcine BioMed is exploring collaboration with POC Medical Systems to form a Joint venture in China.  This Joint venture will focus on advancing the early warning systems est ...

    Detail
  • EN ISO 13485 Audit of Tarcine BioMed Inc. Passed

    “EN ISO 13485 on-site Audit” of Tarcine BioMed Inc. was performed on Feb 9-10, 2015. Our Quality Control System, Management Standard and Employee’s Professionalism were highly recognized and approved to meet the requirement of EN ISO 13485. The validity of ISO certificate is confirmed to be extended. ...

    Detail
Top